Table 1.
Molecular, biochemical, and serological characterization of the nine HCV primary infections
| Subject | Sample | Age (yr)/Sex | Duration of nfection (month) | Log10[HCVi RNA]a | ALT level (IU/mL)b | Result of ELISAc |
| A | 28/F | |||||
| A1 | 0 | 7.12 | 116 | Neg | ||
| A2 | 8 | 6.90 | 69 | Pos | ||
| A3 | 12 | 6.58 | 92 | Pos | ||
| B | 30/M | |||||
| B1 | 0 | 7.27 | 110 | Ne g | ||
| B2 | 6 | 6.50 | 35 | Pos | ||
| B3 | 29 | 5.70 | 37 | Pos | ||
| C | 33/M | |||||
| C1 | 0 | 6.41 | 41 | Pos | ||
| C2 | 24 | 5.25 | 23 | Pos | ||
| C3 | 34 | 5.14 | 10 | Pos |
Number of HCV RNA molecules per mL plasma. Time zero is the time where the first sample was available; other time are times after time zero.
Normal value, < 40 IU/mL.
ELISA: neg, negative; pos, posative.